The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus - EP2886108

The patent EP2886108 was granted to DR Falk Pharma on Nov 2, 2022. The application was originally filed on Dec 23, 2013 under application number EP13199278A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2886108

DR FALK PHARMA
Application Number
EP13199278A
Filing Date
Dec 23, 2013
Status
Patent Maintained As Amended
Sep 30, 2022
Publication Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELLODI PHARMACEUTICALSNov 6, 2019COOLEY UKADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007111978
DESCRIPTIONUS2009264392
DESCRIPTIONWO2009064417
DESCRIPTIONWO2009064457
OPPOSITIONEP1595533
OPPOSITIONUS2007020330
OPPOSITIONUS2010034894
OPPOSITIONUS2011123460
SEARCHEP2151235

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents